Motilal Oswal: Granules India A Quarter Of Record High Revenue Ebitda/PAT  
Medicinal tablets are arranged for a photograph in Mumbai. (Photographer: Dhiraj Singh/Bloomberg)

Motilal Oswal: Granules India A Quarter Of Record High Revenue Ebitda/PAT  

Bookmark
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages. These reports offer BloombergQuint’s subscribers an opportun...